SUSTAINABILITY OF RESPONSE BETWEEN UPADACITINIB AND ADALIMUMAB AMONG PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO METHOTREXATE

被引：0
|
作者：
Nash, Peter [1 ]
Kavanaugh, Arthur [2 ]
Buch, Maya [3 ]
Combe, Bernard [4 ]
Bessette, Louis [5 ]
Song, In-Ho [6 ]
Song, Yanna [6 ]
Suboticki, Jessica [6 ]
Fleischmann, Roy [7 ]
机构：
[1] Griffith Univ, Brisbane, Qld, Australia
[2] Univ Calif San Diego, Sch Med, Div Rheumatol Allergy & Immunol, San Diego, CA 92103 USA
[3] Univ Manchester, Sch Biol Sci, Ctr Musculoskeletal Res, Machester, England
[4] Univ Montpellier, Montpellier, France
[5] Laval Univ, Quebec City, PQ, Canada
[6] Abbvie Inc, N Chicago, IL USA
[7] Southwestern Med Ctr, Metroplex Clin Res Ctr, Dallas, TX USA
来源：
INTERNAL MEDICINE JOURNAL | 2021年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P107
引用
下载
收藏
页码：46 / 47
页数：2
相关论文
共 50 条
  • [21] CHANGES IN ULTRASONOGRAPHIC VASCULARITY UPON INITIATION OF ADALIMUMAB COMBINATION THERAPY IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO METHOTREXATE
    Kaeley, G. S.
    Nishio, M. J.
    Goyal, J. R.
    MacCarter, D. K.
    Wells, A. F.
    Cardoso, A.
    Chen, S.
    Kalabic, J.
    Kupper, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 469 - 469
  • [22] SUSTAINABILITY OF RESPONSE BETWEEN UPADACITINIB AND ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS THROUGH 3 YEARS FROM THE SELECT-COMPARE TRIAL
    Nash, P.
    Kavanaugh, A.
    Buch, M. H.
    Combe, B.
    Bessette, L.
    Song, I. H.
    Shaw, T.
    Song, Y.
    Suboticki, J.
    Fleischmann, R. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 591 - 592
  • [23] Sustainability of Response Between Upadacitinib and Adalimumab in Patients With Rheumatoid Arthritis: Results Through 3 Years from the SELECT-COMPARE Trial
    Nash, Peter
    Kavanaugh, Arthur
    Buch, Maya
    Combe, Bernard
    Bessette, Louis
    Song, In-Ho
    Shaw, Tim
    Song, Yanna
    Suboticki, Jessica
    Fleischmann, Roy
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (07) : 775 - 776
  • [24] Sustainability of Response Between Upadacitinib and Adalimumab in Patients with Rheumatoid Arthritis: Results Through 3 Years from the SELECT-COMPARE Trial
    Nash, Peter
    Kavanaugh, Arthur
    Buch, Maya
    Combe, Bernard
    Bessette, Louis
    Song, In-Ho
    Shaw, Tim
    Song, Yanna
    Suboticki, Jessica
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1730 - 1733
  • [25] SUSTAINABILITY OF RESPONSE BETWEEN UPADACITINIB AND ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS THROUGH 3 YEARS FROM THE SELECT-COMPARE TRIAL
    Buch, Maya H.
    Nash, Peter
    Kavanaugh, Arthur
    Combe, Bernard
    Bessette, Louis
    Song, In-Ho
    Shaw, Tim
    Song, Yanna
    Suboticki, Jessica L.
    Fleischmann, Roy
    RHEUMATOLOGY, 2022, 61
  • [26] SUSTAINABILITY OF RESPONSE BETWEEN UPADACITINIB AND ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS THROUGH 3 YEARS FROM THE SELECT-COMPARE TRIAL
    Nash, Peter
    Kavanaugh, Arthur
    Buch, Maya H.
    Combe, Bernard
    Bessette, Louis
    Song, In-Ho
    Shaw, Tim
    Song, Yanna
    Suboticki, Jessica
    Fleischmann, Roy
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 27 - 27
  • [27] The impact of prior biologic therapy on adalimumab response in patients with rheumatoid arthritis
    Feuchtenberger, M.
    Kleinert, S.
    Scharbatke, E. -C.
    Gnann, H.
    Behrens, F.
    Wittig, B. M.
    Greger, G.
    Tony, H. -P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (03) : 321 - 329
  • [28] Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial
    Combe, Bernard
    Kivitz, Alan
    Tanaka, Yoshiya
    van der Heijde, Desiree
    Simon, J. Abraham
    Baraf, Herbert S. B.
    Kumar, Uma
    Matzkies, Franziska
    Bartok, Beatrix
    Ye, Lei
    Guo, Ying
    Tasset, Chantal
    Sundy, John S.
    Jahreis, Angelika
    Genovese, Mark C.
    Mozaffarian, Neelufar
    Landewe, Robert B. M.
    Bae, Sang-Cheol
    Keystone, Edward C.
    Nash, Peter
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (07) : 848 - 858
  • [29] The efficacy and safety of abatacept or infliximab in patients with rheumatoid arthritis and an inadequate response to methotrexate
    Dougados, M.
    Keiserman, M.
    Codding, C.
    Songcharoen, S.
    Berman, A.
    Nayiager, S.
    Saldate, C.
    Becker, J. C.
    Li, T.
    Schiff, M.
    RHEUMATOLOGY, 2008, 47 : II14 - II15
  • [30] Adalimumab In Combination With High and Low Dose-Methotrexate In Rheumatoid Arthritis Patients With Inadequate Response To Methotrexate: Pharmacokinetic Results From The Musica Study
    Ahmed, Ghada
    Goss, Sandra L.
    Klein, Cheri E.
    Mozaffarian, Neelufar
    Kaeley, Gurjit S.
    Awni, Walid
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S623 - S624
12345